Home › Stocks › RNAZ › Changes
Who bought & sold RNAZ (Q2 2026)
Funds holding (Q2 2026)8
New positions2
Added1
Reduced1
Exited1
As of Q2 2026, 8 institutional funds reported holding RNAZ (TransCode Therapeutics, Inc.): 2 opened new positions, 1 added, 1 trimmed and 1 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.
New positions (2)
| Fund | Shares | Value | Weight |
|---|---|---|---|
| Yorkville Advisors Global, LP New | 19.64K | $121.96K | 0.1 |
| Fidelity Management & Research (FMR) New | 706 | $4.38K | — |
Added to positions (1)
| Fund | Shares | Value | Weight | Change |
|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 677 | $4.20K | — | +449 sh (+196.9%) |
Reduced positions (1)
| Fund | Shares | Value | Weight | Change |
|---|---|---|---|---|
| UBS Group AG | 2.89K | $17.93K | — | -5.41K sh (-65.2%) |
Exited positions (1)
Held in the prior quarter but not reported in the latest filing.
| Fund | Shares | Value | Weight |
|---|---|---|---|
| Geode Capital Management Exited | 12.74K | $109.69K | — |